Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort

CDC in early onset SLE is not uncommon. Indeed, one-third of patients achieved LupusCDC-GCon in at least one evaluation. More severe disease, characterised by active renal and neuropsychiatric manifestations represented a risk factor for failure to achieve LupusCDC. The lower incidence of LupusCDC-GCoff suggested the difficulty in discontinuing GC treatment in early disease phase.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Rheumatology
Published
2024-11-19
DOI
https://doi.org/10.55563/clinexprheumatol/dagoie
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort

B. Frediani, Micaela Fredi, Francesca Bellisai, Gian Domenico Sebastiani et al.
Clinical and Experimental Rheumatology
Systemic Lupus Erythematosus Research
article

Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort

B. Frediani, Micaela Fredi, Francesca Bellisai, Gian Domenico Sebastiani, L. Coladonato, I. Prevete, Anna Zanetti, D. Rozza, A. Bortoluzzi, Marcello Govoni, Matteo Piga, Alberto Cauli, Chiara Tani, Carlo Alberto Scirè, Fulvia Ceccarelli, Andrea Doria, Francesca Romana Spinelli, Florenzo Iannone, Marta Mosca, Luca Iaccarino, Fabrizio Conti
article en

Abstract

CDC in early onset SLE is not uncommon. Indeed, one-third of patients achieved LupusCDC-GCon in at least one evaluation. More severe disease, characterised by active renal and neuropsychiatric manifestations represented a risk factor for failure to achieve LupusCDC. The lower incidence of LupusCDC-GCoff suggested the difficulty in discontinuing GC treatment in early disease phase.

Clinical and Experimental RheumatologyVol. 44(3)
University of Siena (IT), University of Padua (IT), University of Cagliari (IT), Azienda Ospedaliera San Camillo-Forlanini (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Arcispedale Sant'Anna (IT), Società Italiana di Reumatologia (IT), Azienda Ospedaliera Universitaria Pisana (IT), University of Bari Aldo Moro (IT), University of Brescia (IT), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 41%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.